bimiralisib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for bimiralisib, covering 2022-01-20 to 2022-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations [Phase 2]